YFY Biotech Management Company
6
27M
6
0.32
2
- Stages of investment
- Areas of investment
Summary
YFY Biotech Management Company appeared to be the VC, which was created in 2003. The leading representative office of defined VC is situated in the Taipei. The company was established in Asia in Taiwan.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline TaiGen Biotechnology, Elixir Pharmaceuticals, Nereus Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. When startup sums 2 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Test and Measurement, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - Taiwan.
This YFY Biotech Management Company works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2006. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2007.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the YFY Biotech Management Company, startups are often financed by China Development Industrial Bank (CDIB), Pacific Venture Group, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Taiwan Development Fund, MPM Capital, YFY Inc.. In the next rounds fund is usually obtained by Taiwan Development Fund, Roche Venture Fund, Physic Ventures.
Besides them, we counted 1 critical employee of this fund in our database.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.32
- Investments by industry
- Biotechnology (6)
- Pharmaceutical (3)
- Health Care (3)
- Medical (3)
- Product Design (1) Show 3 more
- Investments by region
-
- United States (3)
- Taiwan (3)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 89M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Elixir Pharmaceuticals | 27 Nov 2006 | Biotechnology, Pharmaceutical, Diabetes | Late Stage Venture | 31M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.